PolyPhil® Next - 1x2ml
78,00 €
PolyPhil® Next is an advanced skin injectable that combines high-purity polynucleotide and non-crosslinked hyaluronic acid. Engineered to rejuvenate and enhance skin quality, it promotes cellular regeneration, improves hydration, and restores elasticity. The formulation is especially effective for mature, dehydrated, or compromised skin—reducing fine lines, resurfacing texture, and improving tone with sustained results. Ideal for areas like the face, neck, décolleté, hands, and scarred or stretch-marked skin.
In Stock
- Category: Polynucleotides
- Brand: PolyPhil®
- Manufacturer: CROMA
- SKU: PLPL-0002
- Tags: Face , Neck , Body , Hydration , Stretch Marks , Stretch mark reduction , Scars , Fine Lines , Sagging Skin , Polynucleotides , Non-cross-linked HA
-
Share:
-
- Polynucleotides: 20mg
- Non-crosslinked Hyaluronic Acid: 20mg
- Mature or dehydrated skin needing
revitalization
- Fine lines, wrinkles, and sagging texture
- Scars and stretch marks (striated or
atrophic)
- Maintenance injectable for pre- or
post-aesthetic care
- Skin quality enhancement before fillers or
resurfacing treatments
- 1 x 2 ml syringe
- 2 x 30G (13 mm) sterile needles
Results may last up to
12 months depending on age, skin quality, genetics, lifestyle, sun exposure.
PolyPhil® is an innovative line of injectable treatments developed by Croma-Pharma, focusing on the use of long-chain polynucleotides for skin rejuvenation. These polynucleotides promote collagen production and improve skin hydration, helping to reduce fine lines, wrinkles, and overall skin laxity. PolyPhil® treatments are designed to enhance skin texture and elasticity, offering a natural-looking and long-lasting improvement. Suitable for various skin types, PolyPhil® injectables provide a non-surgical solution for achieving youthful, radiant skin. Trusted by aesthetic professionals, these products are ideal for those looking to revitalize their complexion safely and effectively.
Related Links:
Croma-Pharma GmbH, founded in 1976 by pharmacists Karin and Gerhard Prinz, is a globally recognized leader in the field of minimally invasive aesthetics. Headquartered in Leobendorf, Austria, Croma specializes in the development and production of high-quality hyaluronic acid syringes and a comprehensive range of aesthetic products. The company's portfolio includes botulinum toxin, hyaluronic acid fillers, lifting threads, biostimulators, and advanced skincare solutions. With a robust presence in over 80 markets worldwide, including the US, Canada, China, and Australia, Croma operates 13 subsidiaries across Europe and Brazil, and collaborates with 60 exclusive export partners. Their innovative products, such as the EXO|E Revitalizing Serum, demonstrate their commitment to combining science with luxury, ensuring effective and safe treatments for their customers. Croma also engages in contract manufacturing for orthopaedics and ophthalmology, further diversifying their expertise and market reach. As a family-owned business, Croma continues to support healthcare professionals by providing cutting-edge, minimally invasive aesthetic solutions that help patients achieve their best possible appearance.
Related Links:
Please note that on occasion product package design can change, we will always
strive to show the present design where possible
*The majority of our products are designed for professional use by doctors and
specialists, by purchasing said product(s) you agree to supply on request formal
proof of medical/professional training. Said product(s) are not intended for
personal or home use.
Please note this product has contraindications for use. It is recommended that
all Healthcare professionals familiarise themselves with these contraindications
and precautions by reading the instructions provided.